Compare Diamondback Energy Inc (FANG) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diamondback Energy Inc vs ImmunityBio Inc. Common Stock — how do they compare? Diamondback Energy Inc trades at $190.41 (market cap $53.67B), while ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.51B). The key difference: Diamondback Energy Inc is far larger — about 5.1× ImmunityBio Inc. Common Stock's market cap, and Diamondback Energy Inc pays a 2.3% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Diamondback Energy Inc for 69 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| FANG | IBRX | |
|---|---|---|
Market Cap | $53.67B | $10.51B |
Volume | 2,250,644 | 10,445,785 |
Sector | Energy | Health |
52-Week High | $213.69 | $11.55 |
52-Week Low | $137.29 | $1.98 |
Typical Hold Time | 69 Days | 0 Days |
Enterprise Value | $65.83B | $10.97B |
Dividend Yield | 2.3% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Diamondback Energy (FANG) trades at $184.38, down 0.32% on the day, with a bearish technical signal from moving averages despite neutral oscillators. The company shows strong revenue growth from $14.93B in 2025 to $17.0B projected for 2026, though net margins have compressed from 45.84% in 2022 to 8.63% expected in 2026. Recent earnings beat expectations in Q1 and Q2 2026, and analyst consensus remains strongly bullish with a $231.77 price target representing 26% upside.
FANG presents a compelling growth story with solid operational cash flow generation and strategic positioning in the Permian Basin. Key risks include oil price volatility and margin compression, but strong institutional support and 90% buy ratings suggest confidence in the company's long-term prospects. The upcoming Q3 2026 earnings report on November 2nd will be crucial for validating current growth trajectory.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Diamondback Energy Inc
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2021, the company reported net proven reserves of 1.8 billion barrels of oil equivalent. Net production averaged about 375,000 barrels per day in 2021, at a ratio of 60% oil, 20% natural gas liquids, and 20% natural gas.
Read more on FANG →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
